Impact of previous HIV resistance and virologic failures on virologic outcome following a switch to dolutegravir with 2 NRTIs among people living with HIV.
Sangaré MN, Baril JG, de Pokomandy A, Laprise C, Deshaies C, Klein M, Thomas R, Tremblay C, Roger M, Pexos C, Greenwald Z, Machouf N, Durand M, Hardy I, Dakouo M, Laporte L, Trottier H.
Sangaré MN, et al.
Medicine (Baltimore). 2020 Nov 20;99(47):e23335. doi: 10.1097/MD.0000000000023335.
Medicine (Baltimore). 2020.
PMID: 33217873
Free PMC article.